Impact of the 2022 ATS/ERS update criteria on the bronchodilator responsiveness test result

• Author(s): Martins, B. ; Marinho, A. ; Amorim, Pedro
• Date: 2024
• Persistent ID: http://hdl.handle.net/10400.22/31116
• Origin: Repositório Científico do Instituto Politécnico do Porto
• Document Type: Letter to the editor
• Language: English
• Contributor(s): REPOSITÓRIO P.PORTO

Description

Bronchodilator response (BDR) is a measurement of the degree of volume and airflow improvement in response to an inhaled short-acting bronchodilator. It is widely used in clinical practice to diagnose respiratory diseases such as chronic obstructive pulmonary disease (COPD) or asthma, to assess asthma control, and predict the response to inhaled treatment.